DETAILS, FICTION AND API MANUFACTURING

“The current scenario has uncovered some structural weaknesses during the EU’s medicines source chain as well as a superior dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides said. She recommended that offer chain difficulties be dealt with within an EU pharmaceutical system predicted to generally